Li Y, Hu X Z, Liu C Y, Tao X P, Wang R, Lu R, Li Y, Pu Y, Mu C R, Xu J H, Fu H M
Department of Pulmonary and Critical Care Medicine, Kunming Children's Hospital, Yunnan Provincial Key Laboratory of Children's Major Diseases Research, Kunming 650034, China.
Department of Pediatrics, the People's Hospital of Lincang, Lincang 677099, China.
Zhonghua Er Ke Za Zhi. 2024 May 2;62(5):451-456. doi: 10.3760/cma.j.cn112140-20231201-00406.
To investigate the clinical characteristics of 130 children with severe SARS-CoV-2 infection in Yunnan province after the relaxation of non-pharmaceutical interventions, and analyze the risk factors for mortality. This study is a retrospective case summary that analyzed the demographic data, underlying diseases, clinical diagnoses, disease outcomes, and laboratory results of 130 children with severe COVID-19 infections admitted to nine top-tier hospitals in Yunnan Province from December 2022 to March 2023. According to the prognosis, the patients were divided into survival group and death group. The clinical and laboratory data between the two groups were compared, and the risk factors of death were evaluated. The test and Mann-Whitney test were employed to compare between groups, while Spearman correlation test and multiple Logistic regression were used to analyze the risk factors for death. The predictive value of independent risk factors was evaluated by receiver operating characteristic curve. The 130 severe patients included 80 males and 50 females with an onset age of 28.0 (4.5, 79.5) months. There were 97 cases in the survival group and 33 cases in the death group with no significant differences in gender and age between the two groups (>0.05). Twenty-five cases (19.2%) out of the 130 patients had underlying diseases, and the number with underlying diseases was significantly higher in death group than in survival group (36.4% (12/33) . 13.4%(13/97), =8.36, =0.004). The vaccination rate in the survival group was significantly higher than that in the death group (86.1% (31/36) . 7/17, =9.38, =0.002). A total of 42 cases (32.3%) of the 130 patients were detected to be infected with other pathogens, but there was no significant difference in the incidence of co-infection between the death group and the survival group (39.3%(13/33) . 29.9% (29/97), =1.02, >0.05). Among the 130 cases, severe respiratory cases were the most common 66 cases (50.8%), followed by neurological severe illnesses 34 cases (26.2%) and circulatory severe 13 cases (10%). Compared to the survival group, patients in the death group had a significantly higher levels of neutrophil, ferritin, procalcitonin, alanine aminotransferase, lactate dehydrogenase, creatine kinase isoenzyme, B-type natriuretic peptide, interleukin-6 and 10 (6.7 (4.0, 14.0) . 3.0 (1.6, 7.0)×10/L, 479 (298, 594) 268 (124, 424) μg/L, 4.8 (1.7, 10.6) . 2.0 (1.1, 3.1) μg/L, 66 (20, 258) 23 (15, 49) U/L, 464 (311, 815) 304 (252, 388) g/L, 71(52, 110) 24(15, 48) U/L, 484 (160, 804) 154 (26, 440) ng/L, 43 (23, 102) 19 (13, 27) ng/L, 216 (114, 318) 86 (45, 128) ng/L, =-4.21, -3.67, -3.76, -3.31, -3.75, -5.74, -3.55, -4.65, -5.86, all <0.05). The correlated indexes were performed by multivariate Logistic regression and the results showed that vaccination was a protective factor from death in severe cases (=0.01, 95% 0-0.97, =0.049) while pediatric sequential organ failure assessment (PSOFA) (=3.31, 95% 1.47-7.47, =0.004), neutrophil-to-lymphocyte ratio (NLR) (=1.56, 95% 1.05-2.32, =0.029) and D dimer (=1.49, 95% 1.00-1.02, =0.033) were independent risk factors for death (all <0.05). The area under the curve of the three independent risk factors for predicting death were 0.86 (95% 0.79-0.94), 0.89 (95% 0.84-0.95) and 0.87 (95% 0.80-0.94), all <0.001, and the cut-off values were 4.50, 3.66 and 4.69 mg/L, respectively. Severe SARS-CoV-2 infection can occur in children of all ages, primarily affecting the respiratory system, but can also infect the nervous system, circulatory system or other systems. Children who died had more severe inflammation, tissue damage and coagulation disorders. The elevations of PSOFA, NLR and D dimer were independent risk factors for death in severe children.
为探讨云南省130例新型冠状病毒严重急性呼吸综合征(SARS-CoV-2)感染儿童在非药物干预措施放宽后的临床特征,并分析死亡危险因素。本研究为回顾性病例总结,分析了2022年12月至2023年3月期间云南省9家顶级医院收治的130例新型冠状病毒肺炎(COVID-19)重症感染儿童的人口统计学数据、基础疾病、临床诊断、疾病转归及实验室检查结果。根据预后情况,将患者分为存活组和死亡组。比较两组间的临床和实验室数据,并评估死亡危险因素。采用t检验和Mann-Whitney检验进行组间比较,采用Spearman相关检验和多因素Logistic回归分析死亡危险因素。通过绘制受试者工作特征曲线评估独立危险因素的预测价值。130例重症患者中,男性80例,女性50例,发病年龄为28.0(4.5,79.5)个月。存活组97例,死亡组33例,两组性别和年龄差异无统计学意义(P>0.05)。130例患者中25例(19.2%)有基础疾病,死亡组有基础疾病的人数显著高于存活组(36.4%(12/33)对13.4%(13/97),χ²=8.36,P=0.004)。存活组的疫苗接种率显著高于死亡组(86.1%(31/36)对7/17,χ²=9.38,P=0.002)。130例患者中共有42例(32.3%)检测出感染其他病原体,但死亡组和存活组的合并感染发生率差异无统计学意义(39.3%(13/33)对29.9%(29/97),χ²=1.02,P>0.05)。130例病例中,重症呼吸病例最为常见,共66例(50.8%),其次为重症神经系统疾病34例(26.2%)和重症循环系统疾病13例(10%)。与存活组相比,死亡组患者的中性粒细胞、铁蛋白、降钙素原、谷丙转氨酶、乳酸脱氢酶、肌酸激酶同工酶、B型利钠肽、白细胞介素-6和10水平显著升高(6.7(4.0,14.0)对3.0(1.6,7.0)×10⁹/L,479(298,594)对268(124,424)μg/L,4.8(1.7,10.6)对2.0(1.1,3.1)μg/L,66(20,258)对23(15,49)U/L,464(311,815)对304(252,388)g/L,71(52,110)对24(15,48)U/L,484(160,804)对154(26,440)ng/L, 43(23,102)对19(13,27)ng/L, 216(114,318)对86(45,128)ng/L,t=-4.21, -3.67, -3.76, -3.31, -3.75, -5.74, -3.55, -4.65, -5.86,均P<0.05)。进行多因素Logistic回归分析相关指标,结果显示接种疫苗是重症病例死亡的保护因素(P=0.01,95%CI 0.00-0.97,P=0.049),而儿童序贯器官衰竭评估(PSOFA)(P=3.31,95%CI 1.47-7.47,P=0.004)、中性粒细胞与淋巴细胞比值(NLR)(P=1.56,95%CI 1.05-2.32,P=0.029)和D-二聚体(P=1.49,95%CI 1.00-2.21,P=0.033)是死亡的独立危险因素(均P<0.05)。预测死亡的三个独立危险因素的曲线下面积分别为0.86(95%CI 0.79-0.94)、0.89(95%CI 0.84-0.95)和0.87(95%CI 0.80-0.94),均P<0.001,截断值分别为4.50、3.66和4.69mg/L。SARS-CoV-2严重感染可发生于各年龄段儿童,主要影响呼吸系统,但也可感染神经系统、循环系统或其他系统。死亡儿童存在更严重的炎症、组织损伤和凝血障碍。PSOFA、NLR和D-二聚体升高是重症儿童死亡的独立危险因素。